Holter glycmique et dpistage du diabte chez lenfant atteint de mucoviscidose

[1]  I. Durieu,et al.  [Cystic fibrosis in 2008]. , 2008, La Revue de medecine interne.

[2]  I. Durieu,et al.  [Cystic fibrosis in 2008]. , 2008, La Revue de medecine interne.

[3]  M. Pinget,et al.  Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  G. Velho,et al.  Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. , 2008, The Journal of pediatrics.

[5]  R. Rabasa-Lhoret,et al.  Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  E. Mathiesen,et al.  Cystic Fibrosis–Related Diabetes , 2006, Diabetes Care.

[7]  V. Raia,et al.  Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? , 2005, Diabetes care.

[8]  E. Sims,et al.  Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. , 2005, Diabetes care.

[9]  Y. Berthiaume,et al.  Diabetes: a major co-morbidity of cystic fibrosis. , 2005, Diabetes & metabolism.

[10]  S. Butler,et al.  Epidemiology of cystic fibrosis-related diabetes. , 2005, The Journal of pediatrics.

[11]  M. Ballmann,et al.  New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis , 2005, European Respiratory Journal.

[12]  A. Hattersley,et al.  Conventional measures underestimate glycaemia in cystic fibrosis patients , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[13]  M. Zamora,et al.  Impact of cystic fibrosis-related diabetes (CFRD) on lung transplant outcomes , 2004 .

[14]  D. Turck.  Question 1 Quelle influence de l'état nutritionnel sur l'évolution de la mucoviscidose? Aspect physiopathologique des troubles nutritionnels au cours de la mucoviscidose , 2003 .

[15]  H. Mosnier-Pudar.  Question 4 Quelles strategies diagnostiques et thérapeutiques des troubles du metabolisme glucidique au cours de la mucoviscidose? Diabète de la mucoviscidose : physiopathologie et critères diagnostiques des troubles du métabolisme glucidique , 2003 .

[16]  P. Bretones.  Question 4 Quelles stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose? Stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose , 2003 .

[17]  A. Hattersley,et al.  Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. , 2003, Diabetes care.

[18]  M. Corey,et al.  Glucose intolerance in children with cystic fibrosis. , 2003, The Journal of pediatrics.

[19]  A. Hattersley,et al.  Clinical improvement in cystic fibrosis with early insulin treatment , 2002, Archives of disease in childhood.

[20]  F. Kaufman,et al.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. , 2001, Diabetes care.

[21]  M. Polak,et al.  Cystic fibrosis‐related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy * , 2001, Acta paediatrica.

[22]  S. Bell,et al.  Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. , 2000, JOP : Journal of the pancreas.

[23]  V. Raia,et al.  Continuous Glucose Monitoring System in the Screening of Early Glucose Derangements in Children and Adolescents with Cystic Fibrosis , 2008, Journal of pediatric endocrinology & metabolism : JPEM.

[24]  P. Bretones.  Stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose , 2003 .

[25]  T J Cole,et al.  Body Mass Index variations: centiles from birth to 87 years. , 1991, European journal of clinical nutrition.